LINC00662 and osteosarcoma: Furthermore, LINC00662 has been shown to promote tumor progression in various cancers, including gallbladder cancer (Pérez-Moreno et al., 2024), osteosarcoma (Zhang et al., 2023), and melanoma (Luo et al., 2024).